These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 34051063)

  • 1. Co-Targeting Plk1 and DNMT3a in Advanced Prostate Cancer.
    Zhang Z; Cheng L; Zhang Q; Kong Y; He D; Li K; Rea M; Wang J; Wang R; Liu J; Li Z; Yuan C; Liu E; Fondufe-Mittendorf YN; Li L; Han T; Wang C; Liu X
    Adv Sci (Weinh); 2021 Jul; 8(13):e2101458. PubMed ID: 34051063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A miR-361-5p/ ORC6/ PLK1 axis regulates prostate cancer progression.
    Liu Z; Zhang Y; Yu L; Zhang Z; Li G
    Exp Cell Res; 2024 Jul; 440(1):114130. PubMed ID: 38885805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of polo-like kinase 1 (Plk1) enhances the antineoplastic activity of metformin in prostate cancer.
    Shao C; Ahmad N; Hodges K; Kuang S; Ratliff T; Liu X
    J Biol Chem; 2015 Jan; 290(4):2024-33. PubMed ID: 25505174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of polo-like kinase (Plk) 1 via siRNA causes induction of apoptosis and impairment of mitosis machinery in human prostate cancer cells: implications for the treatment of prostate cancer.
    Reagan-Shaw S; Ahmad N
    FASEB J; 2005 Apr; 19(6):611-3. PubMed ID: 15661849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting the PLK1-FOXO1 pathway as a novel therapeutic approach for treating advanced prostate cancer.
    Gheghiani L; Shang S; Fu Z
    Sci Rep; 2020 Jul; 10(1):12327. PubMed ID: 32704044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevating PLK1 overcomes BETi resistance in prostate cancer via triggering BRD4 phosphorylation-dependent degradation in mitosis.
    Zhang Y; Fong KW; Mao F; Wang R; Allison DB; Napier D; He D; Liu J; Zhang Y; Chen J; Kong Y; Li C; Li G; Liu J; Li Z; Zhu H; Wang C; Liu X
    Cell Rep; 2024 Jul; 43(7):114431. PubMed ID: 38968071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plk1 is upregulated in androgen-insensitive prostate cancer cells and its inhibition leads to necroptosis.
    Deeraksa A; Pan J; Sha Y; Liu XD; Eissa NT; Lin SH; Yu-Lee LY
    Oncogene; 2013 Jun; 32(24):2973-83. PubMed ID: 22890325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plk1 Inhibition Enhances the Efficacy of BET Epigenetic Reader Blockade in Castration-Resistant Prostate Cancer.
    Mao F; Li J; Luo Q; Wang R; Kong Y; Carlock C; Liu Z; Elzey BD; Liu X
    Mol Cancer Ther; 2018 Jul; 17(7):1554-1565. PubMed ID: 29716963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plk1-dependent microtubule dynamics promotes androgen receptor signaling in prostate cancer.
    Hou X; Li Z; Huang W; Li J; Staiger C; Kuang S; Ratliff T; Liu X
    Prostate; 2013 Sep; 73(12):1352-63. PubMed ID: 23661607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccinia-related kinase 2 drives pancreatic cancer progression by protecting Plk1 from Chfr-mediated degradation.
    Zhu H; Li Q; Zhao Y; Peng H; Guo L; Zhu J; Jiang Z; Zeng Z; Xu B; Chen S
    Oncogene; 2021 Jul; 40(28):4663-4674. PubMed ID: 34140642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FRET-Based Sorting of Live Cells Reveals Shifted Balance between PLK1 and CDK1 Activities During Checkpoint Recovery.
    Lafranchi L; Müllers E; Rutishauser D; Lindqvist A
    Cells; 2020 Sep; 9(9):. PubMed ID: 32961751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer.
    Zhang Z; Chen L; Wang H; Ahmad N; Liu X
    Cell Cycle; 2015; 14(13):2142-8. PubMed ID: 25927139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the PLK1-Coupled Cell Cycle Machinery Overcomes Resistance to Oxaliplatin in Colorectal Cancer.
    Yu Z; Deng P; Chen Y; Liu S; Chen J; Yang Z; Chen J; Fan X; Wang P; Cai Z; Wang Y; Hu P; Lin D; Xiao R; Zou Y; Huang Y; Yu Q; Lan P; Tan J; Wu X
    Adv Sci (Weinh); 2021 Dec; 8(23):e2100759. PubMed ID: 34881526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PDK1 signaling toward PLK1-MYC activation confers oncogenic transformation, tumor-initiating cell activation, and resistance to mTOR-targeted therapy.
    Tan J; Li Z; Lee PL; Guan P; Aau MY; Lee ST; Feng M; Lim CZ; Lee EY; Wee ZN; Lim YC; Karuturi RK; Yu Q
    Cancer Discov; 2013 Oct; 3(10):1156-71. PubMed ID: 23887393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nitric oxide down-regulates polo-like kinase 1 through a proximal promoter cell cycle gene homology region.
    Zhang J; Wang S; Kern S; Cui X; Danner RL
    J Biol Chem; 2007 Jan; 282(2):1003-9. PubMed ID: 17121839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of polo-like kinase 1 (Plk1) in mitotic arrest by inhibition of mitogen-activated protein kinase-extracellular signal-regulated kinase-ribosomal S6 kinase 1 (MEK-ERK-RSK1) cascade.
    Li R; Chen DF; Zhou R; Jia SN; Yang JS; Clegg JS; Yang WJ
    J Biol Chem; 2012 May; 287(19):15923-34. PubMed ID: 22427657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Co-targeting PLK1 and mTOR induces synergistic inhibitory effects against esophageal squamous cell carcinoma.
    Liu TT; Yang KX; Yu J; Cao YY; Ren JS; Hao JJ; Pan BQ; Ma S; Yang LY; Cai Y; Wang MR; Zhang Y
    J Mol Med (Berl); 2018 Aug; 96(8):807-817. PubMed ID: 29959473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. USP7 is a novel Deubiquitinase sustaining PLK1 protein stability and regulating chromosome alignment in mitosis.
    Peng Y; Liu Y; Gao Y; Yuan B; Qi X; Fu Y; Zhu Q; Cao T; Zhang S; Yin L; Li X
    J Exp Clin Cancer Res; 2019 Nov; 38(1):468. PubMed ID: 31730000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PLK1 (polo like kinase 1) inhibits MTOR complex 1 and promotes autophagy.
    Ruf S; Heberle AM; Langelaar-Makkinje M; Gelino S; Wilkinson D; Gerbeth C; Schwarz JJ; Holzwarth B; Warscheid B; Meisinger C; van Vugt MA; Baumeister R; Hansen M; Thedieck K
    Autophagy; 2017 Mar; 13(3):486-505. PubMed ID: 28102733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polo-like kinase 1 (PLK1) signaling in cancer and beyond.
    Iliaki S; Beyaert R; Afonina IS
    Biochem Pharmacol; 2021 Nov; 193():114747. PubMed ID: 34454931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.